SINGLE-PORT VATS vs. 3-PORT-VATS LOBECTOMY/SEGMENTECTOMY FOR NON SMALL CELL LUNG CANCER PATIENTS. A RANDOMISED CLINICAL TRIAL INVESTIGATING PAIN INTENSITY AND POST THORACOTOMY PAIN-SYNDROME

Not Applicable

• Conditions: pain after anatomical resection of lung cancer; C34.9; Bronchus or lung, unspecified

• Registration Number: DRKS00014987
• Lead Sponsor: Thoraxchirurgie Lungenklinik MerheimKliniken der Stadt Köln GgmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-07-16
• Study Completion: 2021-09-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 134

Inclusion Criteria

age = 18, NSLC in clinical stage IA-IB and indication for VATS-Lobectomy/Segmentectomy.

Exclusion Criteria

preexisting pain (positive medical history or pain medication the last 3 months), emergency operations, positive history of thoracic operations ipsilateral, age under 18, non NSCLC.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intensity of pain according to nummeric rating scale (NRS) 120 days postoperatively.

Secondary Outcome Measures

Name	Time	Method
Intensity of postoperative pain 5 days postoperatively.<br><br>Neuropathic pain assessment using the leeds score for neuropathic symptoms and signs (LANSS) 120 days after operation<br><br>Postoperative complications-rate<br><br>Comparison of operative data (surgery duration, intraoperative blood loss, chest tube duration, <br>Morfin-equivelant dosis of pain medication used until the 5th postoperative day)